Drug Topics

JULY 16, 2024

The CDC issued a report on the state of the avian influenza, or bird flu, at the end of last week.

199

199

STAT

JULY 16, 2024

DECORAH, Iowa — It was livestock check-in day at the Winneshiek County Fair, and the dairy barn was consumed with a kind of pre-prom anxiety. A cow named Daiquiri was lumbering back from the milking parlor, adjusting to a new schedule that would have her “mammary system” bulging for showtime. Kennedy was getting a fresh shave, tufts of udder-fuzz drifting to the floor, revealing her resplendent venation.

145

145

Drug Topics

JULY 16, 2024

COVID-19 patients had reduced absolute granulocyte, monocyte, and lymphocyte counts at 10 months post-infection compared to noninfected individuals.

Immunization 172

Immunization 172

STAT

JULY 16, 2024

Facing increasing doubts that the U.S. can control the outbreak of avian influenza among dairy cattle, federal officials reiterated on Tuesday that they believe the country can still eliminate the H5N1 virus from dairy cows, even as it continues to spread to new herds. “All the signs that we have are, with good biosecurity, with good farmer participation, we will be able to eliminate this,” Eric Deeble, the acting senior adviser for the H5N1 response at the U.S.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JULY 16, 2024

Data presented show significant advancements in treatment options.

132

132

STAT

JULY 16, 2024

Michael Bloomberg’s donation of $1 billion to Johns Hopkins University to support medical education goes beyond similar gifts to other medical schools. The Bloomberg gift provides support to students in Hopkins’ schools of nursing and public health, not just in its medical school. As health professionals and educators, we are thrilled to see philanthropists supporting the future of medical training in the U.S.

Medical Schools 145

Medical Schools 145

STAT

JULY 16, 2024

The Centers for Disease Control and Prevention just released a trove of data on Americans with disabilities that found that more than a quarter of U.S. adults have a disability — over 70 million people, a bump from prior years. This slice of the population was also much more likely to report long Covid symptoms such as chronic fatigue and brain fog.

144

144

Fierce Healthcare

JULY 16, 2024

UnitedHealth Group has bounced back in the second quarter, reaffirming its guidance | UnitedHealth Group has bounced back in the second quarter, reaffirming its guidance for the year as it posts a profit of $4.2 billion.

130

130

STAT

JULY 16, 2024

A cancer care navigation startup has raised $95 million from prominent tech investors to help payers and providers spend less on cancer patients while improving their health — including by doling out incentive payments to providers and keeping a cut of insurers’ savings. Thyme Care’s Series C round included new investor Concord Health Partners, and repeat investors such as Town Hall Ventures, Andreessen Horowitz, Foresite Capital and CVS Health Ventures, the company tol

Insurance 136

Insurance 136

Pharmacy Times

JULY 16, 2024

Use of semaglutide injections may be linked to an increased risk of blindness in patients with diabetes.

129

129

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 16, 2024

CHICAGO – The FDA’s top food regulator contended Tuesday that the agency could not have done much more to prevent the recent contamination of children’s applesauce with lead. The official, Food and Drug Administration Deputy Commissioner Jim Jones, argued that if companies like the producer of the lead-laced cinnamon in the applesauce “are hell bent about breaking the rules, they’re usually going to get away with it for a little while before they’re stop

FDA 135

FDA 135

Pharmacy Times

JULY 16, 2024

Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.

123

123

STAT

JULY 16, 2024

Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep throat and instead of being prescribed an antibiotic you are told it isn’t urgent and you can wait to treat it. A solution is within reach: It starts with recognizing the power of integrating hepatitis C treatment with addiction care.

135

135

Fierce Pharma

JULY 16, 2024

ICER has issued an access and affordability alert for Verona Pharma’s COPD drug Ohtuvayre. ICER says it is overpriced at an annual rate of $34,500.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 16, 2024

Cardurion Pharmaceuticals, a startup that launched seven years ago with shelved cardiovascular drug candidates from Takeda Pharmaceuticals, has raised $260 million for a Series B round.  The financing was led by Ascenta Capital, a new VC firm that has quietly begun leading biotech investment deals while raising its first fund. Ascenta was started last year by Moderna’s former finance chief Lorence Kim and former head of strategy Evan Rachlin.

131

131

Fierce Healthcare

JULY 16, 2024

In this week’s episode of “Podnosis,” Fierce Healthcare’s Anastassia Gliadkovskaya explores the topic of inequities in maternal and infant health and what one nonprofit is doing to increase transpa | In this week’s episode of “Podnosis,” Fierce Healthcare’s Anastassia Gliadkovskaya explores the topic of inequities in maternal and infant health and what one nonprofit is doing to increase transparency and accountability.

119

119

STAT

JULY 16, 2024

UnitedHealth Group’s CEO said Tuesday that his team was “over-optimistic” about the pace at which providers would reconnect with Change Healthcare after the claims-processing unit sustained a sweeping cyberattack. Andrew Witty’s comments came toward the end of the company’s second-quarter earnings call, in which UnitedHealth disclosed it now expects to shoulder an up to $1.9 billion post-tax hit from the mid-February cyberattack, higher than the $1.6 billion es

Insurance 127

Insurance 127

Fierce Pharma

JULY 16, 2024

Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act. | Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JULY 16, 2024

Most pregnant people are in regular touch with their maternity care providers over the course of nine months, with ever-more-frequent visits, tests, and scans as their due date nears. For many patients, this is the first time in their lives they’ve been in such close, routine contact with the health system. Then, after delivering the child, this attention all but vanishes.

Insurance 121

Insurance 121

Fierce Pharma

JULY 16, 2024

As Johnson & Johnson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds | As Johnson & Johson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds of millions of dollars to settle a longstanding dispute with a clutch of suppliers.

119

119

STAT

JULY 16, 2024

Top of the morning to you. Another steamy day is unfolding here at the Pharmalot campus, where the official mascots are scampering about and enjoying summertime fun.  As for the rest of us, well, we can only dream. But our to-do list will keep us busy, including chats with some interesting folks. Hopefully, you can relate. Either way, it is time to get cracking.

117

117

Drug Topics

JULY 16, 2024

As the end of the DSCSA stabilization period approaches, Scott Mooney, vice president of distribution operations at McKesson, discussed what pharmacists should consider to be prepared.

112

112

Pharmacy Times

JULY 16, 2024

In a meta-analysis, high-dose eicosatetraenoic acid and docosahexaenoic acid had the highest efficacy and lowest dropout rate among pharmacological interventions for migraine.

111

111

Drug Topics

JULY 16, 2024

The companies are marketing products that may violate Federal Trade Commission prohibition of “unfair and deceptive acts in the marketplace.

FDA 112

FDA 112

Fierce Healthcare

JULY 16, 2024

A bipartisan quartet of House representatives have introduced a bill peeling back restrictions on new or expanded physician-owned hospitals. | Advocates and sponsoring legislators say the Physician Led and Rural Access to Quality Care Act would increase access to care in rural areas and increase care affordability.

Hospitals 111

Hospitals 111

Drug Topics

JULY 16, 2024

Look back at some of the amazing insights during McKesson ideaShare, the premier event for community pharmacists.

112

112

pharmaphorum

JULY 16, 2024

Novo Holdings leads $100m financing for Swiss biotech Asceneuron, which is developing an oral tau therapy for Alzheimer's disease

111

111

STAT

JULY 16, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. The weather here in Chicago has been super volatile. We’ve had thunderstorms the last few days, and last night I heard for the first time a  tornado warning. Truly an ominous start to the week!

FDA 111

FDA 111

pharmaphorum

JULY 16, 2024

A digital diagnostic for ADHD called QbTest should be used by the NHS as an add-on to standard assessment, says new NICE guidance

111

111

Fierce Pharma

JULY 16, 2024

With several launches underway and partnerships driving sales growth, Sobi is gaining momentum in its quest to become a force in hematology. | The Swedish drugmaker reported 13% sales growth in its hematology portfolio, which includes brands such as Doptelet, Vonjo and Apellis-partnered Empaveli (or Aspaveli in Europe, which is one of Sobi's territories).

105

105

pharmaphorum

JULY 16, 2024

CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.The three-year plan revolves around parallel programmes in the US and Europe that will include new builds and upgrades and expansion to its existing facilities, according to the German contract development and manufacturing organisation (CDMO).

109

109

PharmaVoice

JULY 16, 2024

An industry reeling from a precarious market is showing signs of stabilizing as the future becomes a little less cloudy, an Evaluate report suggests.

105

105

pharmaphorum

JULY 16, 2024

Natural killer cell therapy specialist Artiva Biotherapeutics has another go at an IPO, hoping to raise up to $135m

108

108